City of Kyiv Outlook Revised to Stable Following Ukraine Outlook Revision; 'B' Rating Affirmed May 03

  • ID: 2024501
  • May 2003
  • Region: Ukraine
  • Standard & Poors
1 of 3


  • Kyiv (City of)
  • Ukraine
  • MORE

LONDON (Standard & Poor's) May 20, 2003--Standard & Poor's Ratings Services said today it revised its outlook on the Ukrainian capital City of Kyiv to stable from negative. At the same time, Standard & Poor's affirmed its 'B' long-term issuer credit rating on the city. The rating action follows Standard & Poor's revision of the outlook on the Republic of Ukraine (B/Stable/B) to stable from negative. (See the media release titled "Ukraine Outlook Revised to Stable Due to Improved Financing Strategy; Ratings Affirmed" published on May 20, 2003, on RatingsDirect, Standard & Poor's Web-based credit analysis system). The stable outlook on Ukraine reflects recent strengthening of the government's financing strategy to meet its annual borrowing requirements. This should help to...

Companies mentioned in this report are:
- Kyiv (City of)
- Ukraine

Action: Outlook Revised

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Kyiv (City of)
- Ukraine

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.